Celiac disease (CD)-associated duodenal dysbiosis has not yet been clearly defi ned, and the mechanisms by which CD-associated dysbiosis could concur to CD development or exacerbation are unknown. In this study, we analyzed the duodenal microbiome of CD patients.
INTRODUCTION
Celiac disease (CD) is an autoimmune, infl ammatory disorder of the small intestine that involves interactions between genetic and environmental factors ( 1 ) . In genetically susceptible individuals (human leukocyte antigen (HLA)-DQ2/DQ8 carriers), ingestion of gluten leads to an abnormal intestinal immune response involving both the adaptive and the innate immunity, which is characterized by a failure to establish and/or maintain tolerance to dietary peptides present in wheat, barley, and rye (particularly wheat gliadin) ( 2 ) and by intestinal damage ( 3 ) . Subsequent studies challenged the gluten-hypersensitivity dogma and suggested that exposure to gluten may not be the only trigger of CD ( 4, 5 ) . In the case of gluten exposure, it remains a mystery why: (i) the frequency of DQ2/DQ8 molecules in the general population is about 30%, but only 1−3% of individuals develop CD ( 1 ); (ii) CD is increasingly being diagnosed in adulthood, many years aft er introduction of gluten in the diet ( 6 ) ; and (iii) the prevalence of CD is rapidly increasing in the western world (although consumption of gliadin-containing food has not increased) ( 7 ) . In this context, other environmental factors such as the intestinal ecosystem have been implicated in the pathogenesis of CD ( 8, 9 ) . Th e rationale for this concept is that the gut microbiota is involved in the following: (i) diff erentiation of the intestinal epithelium; (ii) regulation of gut permeability and immunity; (iii) development of adequate responses to microbial and dietary antigens; and (iv) avoidance of overreactions ( 8, (10) (11) (12) . Consequently, there is growing interest in understanding whether interactions between intestinal microbes and innate immunity of the host could infl uence CD expression by promoting infl ammation and/or impairing mucosal function.
Th e present study was prompted by our previous fi nding of increased proliferation and decreased diff erentiation of intestinal cells toward the secretory goblet cell lineage in children with active CD and in children on a gluten-free diet (GFD) with respect to controls ( 13 ) . Notably, maintenance of a correct number of functional goblet cells is required for homeostasis of the intestinal mucosal environment, and defi ciencies in mucin composition render the mucosa more susceptible to damaging agents (e.g., bacterial infections) in the lumen ( 14 ) . In line with these observations, studies conducted on fecal samples revealed the diff erences between CD patients and healthy controls in terms of microbiota composition and related metabolites ( 8, 9, (15) (16) (17) , whereas data about the mucosa-associated microbiota are inconclusive, mainly because they focused on specifi c groups of bacteria, used diff erent methodologies and specimens, or investigated heterogeneous CD populations in terms of age, clinical conditions, and medications (18) (19) (20) (21) (22) (23) (24) (25) . Th anks to the advent of next-generation sequencing, we can now study simultaneously all the genomes of a microbial community directly recovered from specifi c environments (26) (27) (28) (29) . Th is technique can also reveal changes in the gut microbiome profi le before and aft er therapy ( 25, 30 ) .
Th e aim of this study was to use 16S ribosomal RNA (rRNA) metagenomics to determine the CD-associated duodenal dysbiosis in adult celiac patients and elucidate the mechanisms by which gut CD-associated dysbiosis could concur to CD development or exacerbation.
METHODS

Patients and samples
In this cohort study, 41 unrelated Caucasian individuals were recruited, over 2 years, from among patients attending the Departments of Gastroenterology of the Universities of Salerno and of Roma-Tor Vergata, Italy. Subjects were enrolled from among patients with symptoms suggestive of CD, from among patients with a diagnosis of gastroesophageal refl ux disease (GERD), and from among GFD CD patients undergoing CD follow-up, all of whom consented to participate in the study. Th e exclusion criteria for enrollment were any known food intolerance apart from gluten, IgA defi ciency, treatment with antibiotics, proton pump inhibitors, antiviral or corticosteroids, or assumption of probiotics in the 2 months before sampling. Twenty patients with active CD were on a gluten-containing diet. Th ese patients were positive for CD-specifi c antibodies (IgA anti-endomysium (EMA) and/or IgA anti-tissue transglutaminase 2 (TG2)) and had villous atrophy on histological examination ( 31 ) . Six patients had been on a GFD for at least 2 years, were EMA and anti-TG2 negative, and none of them had villous atrophy on histological examination. HLA-DQ2 and/or -DQ8 molecules were present in 100% of CD and GFD patients. Th e control group was constituted by seven patients with irritable bowel syndrome and/or dyspepsia, fi ve patients with GERD, two patients with chronic gastritis, and one patient with iron loss caused by a fi bromatous uterus.
We collected blood samples (to obtain DNA and serum) and duodenal biopsies, under sterile conditions to avoid contamination, from all enrolled individuals. Biopsies not used for histological examination were immediately cooled in dry ice and stored at −80 °C until genetic analysis, and/or stored in a transport medium for microbiological assays, and/or immediately cultured for in vitro experiments. Th e study was approved by the University of Naples Federico II Ethics Committee (Prot. N. 36/13). Clinical and laboratory features of the 3 study groups are shown in Table 1 .
DNA extraction and 16S rRNA sequencing
Total DNA was extracted from duodenal biopsies (3 mg/sample) using the QIAamp DNA Mini Kit (Qiagen,Venlo, Th e Netherlands) according to the manufacturer's instructions. A 548 bp amplicon, spanning from V4 to V6 variable regions of the 16S rRNA gene, was amplifi ed using modifi ed fusion primers ( Supplementary Table S1 and Supplementary Material online) ( 32 ) . Nextgeneration sequencing reactions were carried out on a 454 Genome Sequencer instrument (Roche, Penzberg, Germany) according to the manufacturer's instructions ( 33 ) . Sequences were obtained in all enrolled subjects and analyzed using QIIME v. 1.9.1 ( Supplementary Material ) ( 34 ) .
Microbiological analysis
Culture-dependent microbiological analysis and isolation of aerobic bacterial species (both adherent and intracellular microbial fl ora) were performed in individuals (9/20 active CD patients and 8/15 controls) for whom duodenal biopsies were available. In this study, we did not consider anaerobic species. Bacterial species
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were identifi ed by mass spectrometry using the Matrix Assisted Laser Desorption/Ionization (MALDI) mass spectrometer (Bruker Daltonics MALDI Biotyper, Fremont, CA; Supplementary Material ). We also cultured and isolated aerobic bacterial species from the oropharynx of 2 control subjects.
Neisseria fl avescens whole-genome sequencing
Genomic DNA from Neisseria fl avescens ( Nf)-isolated strains was prepared as previously reported ( 35 ) . Th eir whole-genome shotgun sequencing was carried out using the Genome Sequencer FLX System (454 Life Sciences and Roche, Basel, Switzerland), as previously described ( Supplementary Material ) ( 36 ) . Sequencing reads were subjected to quality trimming, error correction, and assembly using the SPAdes soft ware ( 37 ) ; default parameters and genome annotation were performed with the RAST Genome Annotation Server ( 38 ) . Custom scripts were used to automate and parse the results of all-against-all tBlastx searches (incorporating 23 representative Neisseria genomes) and to identify clusters of orthologous genes ( COGs ).
Phylogenetic analyses
Th e sequences of 904 unambiguous orthologous single copy genes present in all the considered Neisseria genomes were aligned at the amino acid level using the muscle soft ware ( 39 ) , and alignments were subjected to exclusion of low-quality regions using the GBlocks soft ware ( 40 ) , before concatenation to leave 93,642 amino acid positions. Maximum likelihood bootstrap phylogenetic analysis of protein sequences was performed using the RAxML soft ware ( 41 ) with invariable and 4 variable gammadistributed site rate categories under the WAG amino acid substitution model ( 42 ) .
Iron acquisition systems: Genetic and phenotypic characterization
Th e coding regions of the hemoglobin receptor ( hmbR) gene, of the haptoglobin-hemoglobin ( hpuA/B ), and transferrin ( tbpA/B )-binding protein genes, all involved in iron uptake from diff erent sources, were amplifi ed from the genomic DNA of the isolated Nf strains and sequenced by Sanger methods ( Supplementary  Table S2 and Supplementary Material ). Th e ability to utilize different iron sources was assessed by growing CD-Nf and control-Nf isolates on iron-restricted media supplemented with hemoglobin (Hb), transferrin, and ferric nitrate (FeN) nonahydrate impregnated discs. N. meningitidis ( Nm ) (MC58 serogroup B) was used as pathogenic control bacterium ( Supplementary Material ).
Human and mouse dendritic cells and ex vivo mucosal explants in vitro experiments
Splenic and bone marrow-derived dendritic cells (DCs) were isolated from six C57BL/6 mice diluting 1 ml of a collagenase type IV solution (Sigma-Aldrich, St Lois, MO) in 9 mL RMPI IX and using a mechanical razor blade to disrupt the organs. Aft er tissue disruption, red blood cells were lysed and CD11c + DCs were isolated using magnetic MicroBeads (Miltenyi Biotec, Cambridge, MA) according to the manufacturer's instructions.
Monocyte-derived DCs were derived from peripheral blood monocytes of three healthy volunteers. CD14 + monocytes were isolated from total peripheral blood mononuclear cells using magnetic MicroBeads (Miltenyi Biotec) according to the manufacturer's instructions and cultured for 6 days in the presence of interleukin-4 (IL-4) and granulocyte macrophage colony-stimulating factor (GM-CSF) as previously described ( 43 ) .
Both human and murine DCs were cultured in complete medium in the presence of 0.1 nM retinoic acid and 2 ng/ml transforming grow factor-β , to mimic the small intestinal micro-environment, as previously described ( 44 ) . DCs were stimulated for 48 h with 50 μ g/ml of fi ltered bacterial lysates ( Supplementary Materials and Methods ) from Nf strains isolated from fi ve active CD patients ( Nf 1,2, 3, 7, 8) . Bacterial lipopolysaccharide (LPS; 100ng/ml) was used as a positive control. In addition, for murine DCs, lysates from Serratia marcescens ( Sm, Gammaproteobacteria) isolated from a septic patient were used as pro-infl ammatory controls, whereas Lactobacillus GG ( L GG, Bacilli) was used as a negative non-infl ammatory control as described previously ( 44 ) . Forty-eight hours later, supernatants were harvested and tested Duodenal fragments sampled from three control subjects were collected, oriented, and used for in vitro challenge with CD-Nf to evaluate the infl ammatory properties of this bacterium. We chose to perform ex-vivo challenge with CD-Nf on duodenal mucosa from controls and not from CD patients (active and treated) in order to evaluate whether the infl ammatory eff ect of the bacterium occurred regardless of other contributing factors likely present in CD patients. Mucosal explants were collected in ice-chilled tissue culture medium and cultured for 20 min. Fragments were placed on a stainless-steel mesh positioned over the central well of an organ-culture dish containing culture medium (37 °C), with the epithelium facing upward. One fragment per subject remained untreated and used as reference, whereas the other two fragments were treated with the CD-Nf by using two multiplicities of infection (MOI)-namely, 1:10 and 1:50. Briefl y, fragments were cultured for 6 h, and incubation was stopped by washing, embedding tissues in optimal cutting temperature (OCT, Tissue TEK; Milews Laboratories, Elkhart, IN), and snap freezing them in cooled isopenthane. Samples and supernatants were then stored in liquid nitrogen until analysis. Cryostat sections (5 μ m) of each sample were air dried and then processed. We performed immunofl uorescence analysis of cells positive for the induced markers of infl ammation HLA-DR (the major histocompatibility complex class II molecules) and COX-2 (enzyme rapidly induced by pro-infl ammatory signals in monocytes or macrophages) ( Supplementary Material ). Using ELISA, we also evaluated the levels of interferon-γ , TNF-α , IL-6, IL-23, IL-17A, IL-17F, and IL-12p70 (Procarta Plex multiplex immunoassay; eBioscience) in supernatants of untreated and treated mucosal fragments according to the manufacturer's instructions. All experiments were performed in duplicate.
Internalization and intracellular localization of N. fl avescens in epithelial cells
CaCo-2 epithelial cells were obtained from a Bank of Human and Animal Continuous Cell Lines (CEINGE-Biotecnologie Avanzate, S.C.a R.L. Naples, Italy). Th e cells were grown in Eagle's minimal essential medium (Sigma-Aldrich) and supplemented with 10% fetal bovine serum (Lonza, Basel, Switzerland), 1% l-glutamine (Sigma-Aldrich), and 1% non essential amino acids in the presence of penicillin (50 U/ml) and streptomycin (50 μ g/ml). To distinguish between extracellular and intracellular bacteria, Nf internalization was evaluated by adapting the infection protocol to the immunofl uorescence analysis ( Supplementary Material ) ( 45, 46 ) . Specimens were viewed with the Leica TCS SP5 confocal laser-scanning microscope equipped with a 63x oil immersion objective. Images were processed using Adobe Photoshop CS5.
Statistical analysis
Diff erences in abundance of specifi c taxa across the study groups were identifi ed with analysis of variance together with a Bonferroni correction within QIIME. Diff erences in Operational taxonomic units with P ≤0.05 aft er Bonferroni adjustment were considered statistically signifi cant. To compare the alpha diversity across sample groups, a non-parametric two sample t -test was run using 999 Monte Carlo permutations. Non-parametric multivariate analysis of variance (ADONIS) ( 47 ) using Unifrac distance matrices was used to test the signifi cance of diff erences in beta diversity. Th e mean fold change value (untreated/treated) and the s.e.m. were calculated for each investigated cytokine in supernatants of ex vivo mucosal explants. Between-group comparisons were tested by the Friedman test for paired data with Bonferroni correction and the diff erences considered signifi cant at a P-level < 0.05. A two-way analysis of variance test was used to compare means between diff erent groups of human and murine DCs treated with diff erent bacterial lysates.
RESULTS
Microbiome profi les
Sample metadata obtained from 16S bacterial rRNA sequencing of duodenal samples from all enrolled subjects are summarized in Supplementary Table 3 . Twenty distinct phyla were identifi ed ( Supplementary Figure S1 ) , of which Proteobacteria, Actinobacteria, Bacteroidetes, Firmicutes, and Fusobacteria were the only ones present at a relative abundance >1%. Proteobacteria was the most abundant phylum in the three study groups, whereas the Actinobacteria and Firmicutes phyla were less abundant in the microbiome profi les of active CD patients than in the other two groups ( Figure 1a ) . Class, order, family, and genus in each phylum were also identifi ed ( Figures 1b-e ) . Th ere were no signifi cant diff erences between the three groups within the Firmicutes phylum. Within the Proteobacteria phylum, the Betaproteobacteria class was highly represented in the gut microbiome of active CD patients, although its levels did not directly correlate with disease severity. In addition, within the Betaproteobacteria class, the Neisseriales order ( P =0.009), the Neisseriaceae family ( P =0.01), and the Neisseria genus ( P =0.03) were signifi cantly more abundant in active CD patients than in the other 2 study groups, and the Neisseria genus was the most abundant genus (99.8%) within the Neisseriaceae family ( P <0.05) ( Figure 1e ). Th e Gammaproteobacteria class was less abundant in active CD patients than in the other two study groups ( Figure 1b ) , whereas the Acinetobacter genus was more abundant in GFD patients and controls than in active CD patients, although the diff erence was not signifi cant ( Figure 1e ).
Alpha rarefaction curves (obtained with the QIIME pipeline, Supplementary Material ) showed that bacterial community richness did not diff er between CD patients and controls ( Figure 2a ) . Th e Beta diversity of bacterial communities was statistically significant within the three groups computed with both the unweighted ( P =0.017, R 2 =0.06; ADONIS) and the weighted Unifrac ( P =0.014, R 2 =0.10; ADONIS) method ( Figures 2b, c ) than control microbiomes are to the active or GFD CD microbiomes. Th is fi nding is supported by the tighter clustering of active and GFD CD points compared with control points (see Figures 2b, c ) . Th e high heterogeneity of the volunteers in the control group (which was inevitable given the diffi culty in collecting biopsy samples) caused a slight variability in the microbiome composition, although no significant diff erences were observed within the control group in terms of the presence/absence of dyspepsia or irritable bowel syndrome ( Figure 2b, c , Supplementary Figure S1 and Supplementary Tables  S4 and S5 ). Furthermore, we did not fi nd any correlation between the diff erences in intestinal microbiome composition and the histological features among the controls enrolled in the study.
Microbiological assays
To verify the viability of the aerobic species identifi ed by 16S sequencing, which include Neisseria , we performed standard microbiological cultures of duodenal biopsy specimens. Diff erential analysis (diff erential culture media and mass spectrometry analysis) revealed a cultivable aerobic biodiversity in duodenal microfl ora of the samples tested ( Supplementary Table S6 ). In particular, neither Lactobacillus nor Bacillus cereus (which belong to Firmicutes) was found in the microbiome of the active CD patients, although both are commensal bacteria in the healthy gut. In contrast, Nf was viable in all duodenal mucosa samples from active CD patients (CD-Nf ), with a MALDI-TOF score above 2 (data not shown), but was undetectable in the duodenal mucosa samples from controls ( Figure 2d ). However, we were able to culture and isolate Nf from the oropharynx of two control subjects (control-Nf ), in whom this bacterium is commensal (data not shown).
Genotypic and phenotypic features of the isolated CD-Neisseria fl avescens
Nfs isolated from three active CD patients (namely CD-Nf 1, CD-Nf 2, and CD-Nf 3), whose mucosal intestinal biopsies were showed that bacterial community richness did not differ between CD patients and controls. ( b ) Principal-coordinates analysis applied to the unweighted and ( c ) weighted UniFrac distances shows a difference between CD patients and controls. In fact, both active CD and GFD patients are distinct from controls, which moreover had a random distribution ( P =0.017, R 2 =0.06; ADONIS and P =0.014, R 2 =0.10; ADONIS, respectively). Filled blue squares refer to a subgroup of control subjects affected by gastroesophageal refl ux disease, chronic gastritis, or fi bromatous uterus, whereas opened blue squares refer to a subgroup of controls affected by dyspepsia or irritable bowel syndrome; both these control groups are CD negative. Figures 4b, d and e ). DCs were cultured in the presence of retinoic acid and transforming growth factor-β , both of which are abundant in the small intestinal microenvironment, to mimic physiological intestinal conditions. Aft er 48 h of stimulation, the level of IL-12p40, a cytokine produced by DCs under infl ammatory conditions, was higher in murine splenic DCs treated with CD-Nf strains than in untreated DCs (untreated vs. Nf 1 P =0.0021, vs. Nf 2 P =0.0003, vs. Nf 3 P =0.0031) ( Figures 4a  and b ) and in murine splenic DCs challenged with L GG ( L GG vs. Nf 1 P =0.01, vs. Nf 2 P =0.0016, vs. Nf 3 P =0.0161), a bacterium that colonizes the gut of healthy subjects and that in normal concentrations does not exert an infl ammatory eff ect ( Figure 4b ). Levels of IL-12p40 were also higher in supernatants of DCs treated with the three strains of CD-Nf than in DC supernatants aft er stimulation with bacterial LPS (LPS vs. Nf 1 P =0.0339, vs. Nf 2 P =0.0047, vs. Nf 3 P =0.05) and comparable to or even higher than (as assessed for Nf 2 ( P =0.01) those detected upon challenge with lysates of Sm (Gammaproteobacteria), a bacterium isolated from patients aff ected by sepsis and known to exert pro-infl ammatory eff ects on DCs ( Figure 4b ) ( 51 ) . Th e results of this set of experiments indicate that each of the 3 strains isolated from the small intestinal mucosa of CD patients was able to imprint a pro-infl ammatory phenotype on murine splenic DCs in vitro .
We confi rmed these results in bone marrow-derived murine CD11c + DCs (data not shown). Furthermore, we tested the proinfl ammatory properties of the lysates of Nf strains isolated from active CD subjects on human monocyte-derived DCs ( Figure 4c ) and found that the production of both TNF-α ( Figure 4d ) and IL12p40 ( Figure 4e ) was higher in Nf -stimulated DCs than in either untreated or LPS-treated DCs ( P <0.0001, one-way analysis of variance and multiple comparison analysis with Bonferroni correction). Th is fi nding suggests that Nf strains exert a pro-infl ammatory eff ect on human monocyte-derived DCs. Of note, the Nf10 strain isolated from a pharyngeal swab of a control subject enhanced the production of the pro-infl ammatory cytokines TNF-α when cultured in conditions mimicking the small intestinal environment (medium containing retinoic acid and transforming growth factor-β). Th is may suggest that not only the presence of a specifi c bacterial strain but also particularly the specifi c microenvironment and milieu may determine which eff ect is exerted on immune cells.
To verify the infl ammatory in vitro eff ect of CD-Nf , we exposed ex-vivo mucosal explants from control subjects to CD-Nf bacteria for up to 6 h, and using immunofl uorescence we found increased epithelial expression of the infl ammation markers HLA-DR and COX-2. In particular, HLA-DR expression ( Supplementary Figure S3 ) was enhanced in villus enterocytes, in the basal cytoplasmatic compartment, as well as on the brush border and basolateral membranes. HLA-DR was overexpressed also in the lamina propria, particularly near the surface epithelium. In addition, in experiments with COX-2 (data not shown), the mean number of COX-2-positive epithelial cells increased from 16/100 (untreated mucosa) up to 25/100 aft er CD-Nf challenge. available, and from the oropharynx of one healthy individual (control-Nf ) were subjected to whole-genome shotgun sequencing as reported in the Methods section. Genome assembly and annotation were performed using standard approaches ( 37, 38 ) and resulted in assemblies ranging in size from 2.22 to 2.30 Mb ( Supplementary Table S7 ). Phylogenetic analyses of the tested Nf genomes confi rmed the close phylogenetic relationships between all the strains recovered in the current study and those annotated in GenBank ( http://www.ncbi.nlm.nih.gov/genome/genomes ), namely, the N. fl avescens strains SK114 and NRL 30031, N. mucosa strain C102, and N. subfl ava strain NJ9703 ( Supplementary Figure S2 ) .
We used reciprocal best blast analyses to identify genes present in all CD-Nf genomes, but absent in at least one of the other studied Nf genomes (see above), and in control-Nf . Notably, the isolates from our control-Nf and the two commensal Nf genomes (SK114 and NRL 30031) annotated in GenBank possess neisserial haptoglobin-hemoglobin A/B ( hpuA/B ) and transferrin A/B ( tbpA/B ) binding protein genes but lack the hmbR gene. On the contrary, all isolates from active CD patients (CD-Nf 1, CD-Nf 2, and CD-Nf 3) lack the hpuA/B and tbpA/B genes but possess the hmbR gene (data not shown). Th is result was confi rmed by PCR analysis in 5 CD-Nf samples ( Supplementary Table S8 ). Th e hmbR gene encodes a Hb receptor that has more frequently been associated with disease isolates of N. meningitidis ( Nm ) than with carriage isolates, suggesting that this receptor contributes to Nm -related disease (48) (49) (50) . As the process of iron scavenging from the host is an important virulence attribute of bacterial pathogens, we evaluated the ability of Nf isolated from the duodenal mucosa of CD patients to scavenge iron from Hb and from other sources compared with control-Nf . We observed that, on Mueller-Hinton (MH) agar plus desferal, strains isolated from CD patients (CD-Nf 1, CD-Nf 2, CD-Nf 3, CD-Nf 7, and CD-Nf 8) and Nm (pathogenic positive control) grew well with Hb as the sole iron source, which indicates that these strains express at least one Hb receptor, in agreement with our sequence data. In contrast, the control-Nf strain grew well also using transferrin as an iron source, which indicates that this strain utilizes iron through the hpuA/B and tbpA/B gene systems-a fi nding that is in accordance with our control-Nf genomic sequence and PCR results ( Supplementary Table 8 ).
Internalization of N. fl avescens in epithelial cells
To evaluate how CD-Nf and control-Nf are internalized in the host epithelial cells, we infected CaCo-2 epithelial cells with Nf from two active CD patients (CD-Nf 1 and CD-Nf 7) and used confocal microscopy to compare their intracellular localization with that of control-Nf up to 6 h aft er infection ( Figure 3 ). At the end of the experiment, although CD-Nfs (CD-Nf 1and CD-Nf 7) were internalized (red signals) and seldom colocalized with the marker of the late/endosome-lysosomal pathway (LAMP-1, green signals), control-Nf (CTR-Nf 10) clearly colocalized with LAMP1, indicating that most CD-Nfs escape this intracellular compartment.
In vitro infl ammation effect of CD-Nf
We investigated the pro-infl ammatory properties of CD-Nf bacterial strains in vitro using both murine ( Figure 4a ) and human CD-Nf also promoted the release of infl ammatory cytokines (interferon-γ , TNF-α , IL-6, IL-23, IL-17A, IL-17F, and IL-12p70). In fact, the levels of these cytokines were higher in the supernatants of treated than in untreated biopsies as assessed in organ-culture experiments ( Table 2 ) , and the increase was signifi cant for interferon-γ ( P =0.001), TNF-α ( P <0.011), and IL-23 ( P =0.015). We show that IL-12p70 and IL-23 share the subunit IL-12p40 thus suggesting that there might be an increase in IL-12p40 subunit production.
DISCUSSION
CD-associated duodenal dysbiosis is not yet clearly defi ned, and the mechanisms by which gut CD-associated dysbiosis could concur to CD development or exacerbation remain largely unknown. In the attempt to shed light on this issue, we used 16S rRNA metagenomics to determine whether the duodenum microbiome diff ered among three groups of adult individuals: active CD patients, GFD CD patients, and controls.
Of the fi ve major phyla present with a frequency above 1% in the gut microbiome of our three study groups (Proteobacteria, Actinobacteria, Bacteroidetes, Firmicutes, and Fusobacteria), members of the phylum Proteobacteria were more abundant and those of the Firmicutes and Actinobacteria phyla less abundant in active CD than in either GFD patients or controls. A similar dysbiosis was previously reported in the gut microbiome of four adult CD patients with gastrointestinal symptoms studied by 16S rRNA gene sequencing ( 23 ) . Th e same group of investigators confi rmed this dysbiosis in the gut microbiome of 17 GFD CD patients with persistent symptoms but not in 17 asymptomatic GFD patients ( 52 ) . Similar results were obtained in biopsy specimens from active CD children when compared with GFD and control children ( 25 ) . All the above data support the concept that the gut dysbiosis associated with the active stage of CD is characterized by an increase in Proteobacteria and a decrease in Firmicutes phyla. However, no other group has previously explored how specifi c bacterial species detected in the duodenal mucosa of CD patients could contribute to the CD-associated gut malfunction.
Within the bacterial genera detected in the gut microbiome of the 3 study groups by 16S rRNA gene sequencing, the relative abundance of the Neisseria genus was signifi cantly higher ( P =0.03) in active CD patients (26%), than in either GFD patients (4%) or + DCs isolated from the spleens of C57B6 mice were cultured for 48 h in the presence of retinoic acid (RA) and transforming growth factor-β (TGF-β ) with fi ltered Nf lysates from three active CD patients ( a ). All three tested bacterial lysates promoted the production of interleukin (IL)-12p40 by murine DCs, whereas untreated (stars upon horizontal bars), lipopolysaccharide (LPS)-treated (stars), and L GG-treated DCs did not ( b ). Human monocyte-derived DCs were cultured for 48 h in the presence of RA and TGF-β with fi ltered Nf lysates isolated from active CD patients ( c ). Tumor necrosis factor-α (TNF-α ) levels were higher in supernatants of human DCs treated with Nf 1, Nf 7, and Nf 8 bacterial strains isolated from small intestinal biopsies of CD patients, and in those challenged with Nf 10 isolated from a pharyngeal swab of a control subject ( d ), than in those treated with bacterial LPS, used as a pro-infl ammatory positive control (stars upon horizontal bars) and in untreated (UN) cells ( P <0.0001 for each of the treatments). IL-12p40 levels were higher in supernatants of human DCs challenged with Nf 1,2,3 fi ltered lysates than in those treated with bacterial LPS (stars) used as a proinfl ammatory positive control and in untreated (UN) cells (stars upon horizontal bars) ( e ). Dot plots represent values from three independent experiments. Each experiment was performed in duplicate. A two-way analysis of variance was performed to check for inter-group differences. * P <0.05, ** P <0.01, *** P <0.001, and **** P <0.0001. patients and controls were the reduced levels of Actinobacteria and Firmicutes in the active CD microbiome. Notably, two cultivable bacteria belonging to the Firmicutes phylum ( Lactobacillus and Bacillus cereus) , which are involved in gluten metabolism, were not found in the active CD microbiome. Low levels of Lactobacilli are one of the most consistent fi ndings in both adults and children with active CD ( 16, 18, 21 ) ; however, the relevance of this information is unclear. Th e fecal levels of Firmicutes ( Lactobacillus ) and Actinobacteria were recently reported to be lower in active CD patients than in healthy controls, and this result was associated with diff erences in gluten metabolism among the two groups of individuals ( 53 ) .
We next asked the following questions: (1) Are there genetic and/or phenotypic diff erences between CD-Nf and commensal control-Nf ?; and (2) If there is a diff erence, does that diff erence enable CD-Nf to promote an abnormal response in the intestinal epithelium? To address these questions, we used next-generation sequencing to sequence the whole Nf genome of strains isolated from the gut of active CD patients (CD-Nf 1, CD-Nf 2, and CD-Nf 3) and from the oropharynx of a control subject (control-Nf ). Th en we compared these sequences to those of other pathogenic and commensal Nf genomes present in GenBank. Notably, all CD-Nf and Nm genomes showed genetic diversity of the iron acquisition systems with respect to the control-Nf and the other tested commensal Nf. In fact, the CD-Nf genomes lacked the hpuA/B and tbpA/B genes but possessed the hmbR gene. Th is fi nding was supported by an in vitro test of iron uptake showing that CD-Nf and control-Nf acquired iron from diff erent sources. However, although the hmbR gene has been widely associated with pathogenicity in Nm (48) (49) (50) , the signifi cance of its presence in our CD-Nf genomes remains to be further investigated. Notably, our data show that gene structure and function diff er between CD-Nf and control-Nf .
To answer the second question, we explored the infl ammatory eff ect of CD-Nf because overgrowth of pathogenic bacteria could lead to aberrant activation of the immune system. Interestingly, in vitro , all the Nf strains isolated from 5 adults aff ected by active CD induced an infl ammatory phenotype in human and murine DCs, as shown also for other bacterial strains ( 44 ) . In detail, IL-12p40 and TNF-α levels were higher in pure bacterial lysates from CD-Nf than in lysates stimulated with a control bacterium ( L GG) or with LPS. Th ese fi ndings support the notion that Nf may promote a pro-infl ammatory phenotype in DCs residing in the intestinal mucosa of celiac subjects and thus contribute to the CD immune response characterized by high levels of infl ammatory cytokines. Furthermore, interferon-γ , TNF-α , and IL-23 levels were higher in the culture supernatants of biopsies treated with CD-Nf than in untreated biopsies from controls. Th ese data support our hypothesis that Nf contributes to promoting infl ammation in the small intestine. Whether this infl ammation precedes or follows the onset of full-blown CD remains, however, to be studied. It is feasible that the infl ammatory conditions occurring in the gut of CD patients may favor the colonization of Nf strains thus promoting the maintenance of a pro-infl ammatory immune response; on the other hand, under certain conditions (environmental factors, viral infections, genetic predisposing factors, etc.), Nf colonization of the duodenal tract is favored, and this event could contribute to triggering CD development in genetically susceptible individuals.
Beside modulating the immune response, the microbiota may also play a role in CD by degrading toxic gluten peptides, thereby aiding gluten detoxifi cation in vivo ( 54 ) . In this context, it is noteworthy that members of the Neisseria genus are poorly active against intact and toxic gliadin peptides ( 55 ) . Moreover, CD-Nf could aff ect intracellular traffi cking in two ways: (a) CD-Nf escape from lysosomal degradation could trigger a stress pathway independent of the gliadin peptide pathways; (b) CD-Nf could interfere with the pathway involving the toxic gliadin peptides by following the intracellular pathway previously identifi ed in CaCo-2 cells ( 56 ) . Both these hypotheses deserve further investigation. However, it remains to be established whether the CD-associated bacterial species contributes to the pathogenesis of the disease or whether it is a consequence of it. At present, the induction of infl ammatory responses in DCs and in ex-vivo mucosal explant supports the fi rst possibility.
In conclusion, marked dysbiosis and an abundance of a peculiar CD-Nf strain characterize the duodenal microbiome of active CD patients, which suggests that the CD-associated microbiota could contribute to the many infl ammatory signals in this disorder. IFN-γ , interferon-γ ; IL-6, interleukin-6; TNF-α , tumor necrosis factor-α . a Ex-vivo mucosal explants from three control subjects were treated for 6 h with CD-Nf at a multiplicity of infection (MOI) 1:10 and 1:50, and then levels of infl ammatory cytokines were measured in supernatants of those treated with respect to untreated biopsies. Differences between mean levels were tested by the Friedman test with Bonferroni correction, and the p value is reported under each column. Boldface type indicates statistically signifi cant differences among groups ( P <0.05).
Study Highlights
WHAT IS CURRENT KNOWLEDGE
✓ The gut microbiota has a role in the maintenance of healthy status.
✓ Duodenal dysbiosis has been reported also in celiac disease. ✓ Results about the role of the microbiome in celiac disease development are inconclusive.
WHAT IS NEW HERE
✓ Next-generation sequencing characterization of duodenalassociated microbiomes revealed increased levels of a Neisseria fl avescens strain in adult celiac patients.
✓ This strain possesses peculiar features in hemoglobinrelated and iron-uptake genes.
✓ This CD-associated strain induced infl ammation in dendritic cells and ex-vivo mucosal explants, suggesting that it may concur to amplify CD mucosal derangement.
